Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Nov 16 - Nov 21
Every treatment plan is personalized based on a child's medical history, metabolic health, growth, and long-term goals
The mean percentage change in body weight at week 68 was 14.9% in the semaglutide group vs 2.4% with placebo, for an estimated treatment difference of 12.4 percentage points (95% CI, 13.4 to 11.5)
In adult weight-reduction trials summarized in current Wegovy labeling, nausea was reported in 44% of patients receiving Wegovy 2.4 mg injection compared with 16% receiving placebo
Dipeptidyl peptidase 4 inhibitor sitagliptin maintains -cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study
US$ 26.98
US$ 27.71
US$ 28.68
US$ 28.48
US$ 28.01
US$ 27.77
